|
業務類別
|
Biotechnology |
|
業務概覽
|
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leveragesboth structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable andoperating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs. |
| 公司地址
| 601 Gateway Boulevard, Suite 900, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 457-1978 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.structuretx.com |
| 員工數量
| 220 |
| Dr. Yingli Ma, PhD |
Chief Technology Officer |
美元 429.77K |
23/04/2026 |
| Dr. Blai Coll |
Chief Medical Officer |
美元 492.81K |
23/04/2026 |
| Professor Raymond C. Stevens, PhD |
Director and Chief Executive Officer |
美元 672.09K |
23/04/2026 |
| Mr. Jun Yoon |
Principal Accounting Officer and Chief Financial Officer |
美元 530.53K |
23/04/2026 |
| Dr. Xichen Lin, PhD |
Chief Scientific Officer |
美元 505.31K |
23/04/2026 |
| Mr. Matthew Lang, J.D. |
Chief Operating Officer and General Counsel |
-- |
15/04/2026 |
| Ms. Ashley F. Hall, J.D. |
Chief Development Officer |
-- |
23/04/2026 |
|
|
| Dr. Joanne Waldstreicher, M.D. |
Independent Director |
23/04/2026 |
| Mr. Angus Charles Russell |
Independent Director |
23/04/2026 |
| Dr. Ted W. Love, M.D. |
Independent Director |
23/04/2026 |
| Mr. Eric L. Dobmeier, J.D. |
Independent Director |
23/04/2026 |
| Mr. Daniel G. Welch |
Chairman of the Board |
23/04/2026 |
| Professor Raymond C. Stevens, PhD |
Director and Chief Executive Officer |
23/04/2026 |
| Ms. Sharon E. Tetlow |
Independent Director |
23/04/2026 |
|
|
|
|
